Jobs / United States / Novartis Pharmaceuticals Corporation
Medical Manager
Novartis Pharmaceuticals Corporation · 🇺🇸 Kazakhstan
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles7 certified filings for “Director, Resource Optimization Commercial” (Medical and Health Services Managers) in NJ: $183k–$223k, median $223k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary The Medical Manager of a cluster drives the scientific leadership for one or more assigned therapeutic areas by translating global, international, and local medical directions into impactful country execution. The role provides expert medical guidance, shapes scientific exchange, strengthens external engagement, and ensures high scientific rigor in all medical initiatives. Its partners functionally deliver medical education, insight generation, evidence contributions, and compliant scientific dialogue, supporting lifecycle management and patient centric outcomes. The Medical Manager acts as a key scientific ambassador and connector between internal teams and external medical communities. External medical activities include scientific engagement with healthcare professionals, medical experts, scientific societies, and partners; gathering insights from real-world clinical practice; as well as participation in congresses and projects, while ensuring full compliance with applicable legislation, compliance requirements, pharmacovigilance obligations, and the Company’s internal procedures.The role is designed as a hybrid field/office position, with field presence recognized as a strategically important component and a key focus of the role. Job Description Major accountabilities: • Medical Education & Scientific Communication • Design and execute medical education initiatives, including webinars, scientific sessions, and TA‑specific learning programs. • Organize pre‑, during‑, and post‑congress activities in collaboration with cross‑functional teams. • Produce, adapt, and ensure quality of scientific materials (publications, slide decks, external presentations). • Ensure all content and all scientific, clinical, and educational activities adhere to ERC, local laws, medical governance, and internal compliance standards. • Scientific Engagement • In line with global guidance leads high-level scientific engagement with senior MEs, peer‑to‑peer scientific exchange with Medical Experts and HCP networks, fostering credible, unbiased scientific dialogue. • Build and sustain strong scientific relationships with rising stars, KOLs, and expert communities. • Executes Medical TA‑defined scientific communication priorities and external scientific engagement activities at cluster level, including advisory interactions, expert meetings, and scientific discussions. • Ensure compliant, evidence‑based interactions consistently aligned with Novartis governance. • Ensure external medical activities across the cluster are conducted in alignment with Novartis TA plan, in collaboration with country-level MSL/Medical Manager FTEs. • Insight Generation & Evidence Contribution • Gather actionable external insights from HCPs, MEs, congresses, real‑world practice, and scientific interactions. • Synthesize insights to influence TA direction, identify evidence gaps, and shape medical priorities. • Support publication activities by providing medical and scientific input, as applicable and in line with publication governance and compliance requirements Provide medical input to market access readiness in collaboration with V&A • Medical Community & Partnerships Building • Develop and maintain scientific partnerships with medical societies, academic institutions, and external scientific collaborators across the cluster. • Represent Novartis as a credible scientific voice at congresses, scientific events, and expert forums. • Support external scientific collaboration initiatives across the cluster, as applicable, in line with internal governance and compliance requirements. • Operate fully in line with HQ guidance, Novartis policies, ethical standards, and local regulatory requirements, adhe